Category Archives: Pr Newswire

19,000-square-foot facility reflects the company’s recent growth and continued commitment to the region MORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, today announced the grand opening of its new, 19,000-square-foot corporate headquarters in Morrisville, North Carolina, in the heart of Research Triangle Park. The […]

Clinical update presented at ASCO 2024 for CRB-701 showed continued differentiated safety and encouraging efficacy in patients with metastatic urothelial cancer or cervical cancer CRB-701 Phase 1 dose escalation underway in USA and Europe for patients with metastatic urothelial cancer and other nectin-4 enriched tumors and is on schedule for completion in Q4 2024 Cash […]

HONG KONG, Aug. 6, 2024 /PRNewswire/ — Recently, Hurricane Beryl, a Category 4 storm, wreaked havoc in the southeastern Caribbean, bringing intense winds and heavy rainfall that resulted in at least six fatalities and severe damage in many areas. In the Cumanacoa region of Venezuela, torrential rains caused rivers to overflow, damaging numerous vehicles and collapsing […]

Samsung Biologics to embed PSCI principles into business practices for responsible value chain management Supplier Partnership reaffirms company’s commitment to decarbonize and build resilient supply chains INCHEON, South Korea, Aug. 6, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced today that the company has joined the Pharmaceutical Supply […]

HONG KONG, Aug. 6, 2024 /PRNewswire/ — Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies’ long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, Viva Biotech’s portfolio companies have new updates. Keep reading for […]

NEW YORK, Aug. 6, 2024 /PRNewswire/ — Aquaron Acquisition Corp. (NASDAQ: AQU, the “Company“), a special purpose acquisition company, announced today that HUTURE Ltd. (“Huture“) has deposited into the Company’s trust account (the “Trust Account“) an aggregate of $20,000, in order to extend the period of time the Company has to complete a business combination […]

Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON, Aug. 6, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the Board has appointed Matti Shem Tov, former CEO of ProQuest, as the Company’s next CEO, effective August 9, 2024. Mr. […]

SAN DIEGO, Aug. 05, 2024 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, August 12, 2024, at 4:30 p.m. Eastern Time to discuss the […]

Company expects to commercialize the investigational ARC-EX® System in Q4 2024 and has commenced launch preparations Company preparing to initiate global pivotal trial for investigational ARC-IM® Therapy to address blood pressure instability after spinal cord injury Company expects to advance clinical and development activities for its unique ARC-BCI™ brain-computer interface therapy EINDHOVEN, the Netherlands, Aug. […]

MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 55,200 shares […]